SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is trending following a high-profile Nasdaq debut that saw its valuation surpass two trillion dollars, sparking intense debate between retail investors chasing hype and skeptics questioning the company's lack of profitability and extreme market cap. Community sentiment is deeply divided, with many traders capitalizing on the massive initial volume and volatility, while others warn of a looming 'rug pull' and caution against the limited float.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing intense volatility and record-breaking momentum, with the community fiercely divided between bulls celebrating a historic, AI-fueled climb toward key psychological price levels and bears warning of a potential bubble. Investor sentiment remains heavily focused on aggressive short-squeeze dynamics and the stock's role as a primary driver of broader semiconductor market activity.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is attracting intense investor focus as it secures a milestone inclusion in the Nasdaq-100 index, triggering significant momentum ahead of the SpaceX market debut. The community is actively debating whether to reallocate capital into the SpaceX IPO or maintain positions in Rocket Lab as a strategic, long-term infrastructure play within the evolving space economy.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant market volatility and high trading volume as investors rotate capital into the highly anticipated SpaceX IPO. The community remains deeply divided, with many debating whether the SpaceX debut acts as a liquidity drain on Tesla or a long-term catalyst for a potential future merger between the two companies.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is seeing significant volatility as investors digest the settlement of a high-profile fee dispute with Publicis, a resolution that removes a major narrative overhang for the company. While the community is actively debating the potential for a short squeeze and speculating on further catalysts like potential OpenAI partnerships, many shareholders remain frustrated by the stock's failure to reclaim levels lost during the recent executive leadership turnover.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant volatility as investors rotate capital ahead of the SpaceX IPO, with the community split between concerns of a 'sell-the-news' event and long-term conviction in the stock's direct-to-cell technology. The conversation is heavily focused on the company's upcoming satellite launches and structural partnerships, which many investors view as a necessary foundation for long-term growth despite the current sector-wide pressure.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

The Tema Space Innovators ETF is trending as investors aggressively position themselves ahead of the highly anticipated SpaceX IPO, with community members actively debating whether to hold the ETF as a proxy for SpaceX exposure or if the fund will face volatility once direct shares become available. While many discuss this as a long-term strategic play to gain access to the private space economy, sentiment is split between those loading up on the recent dip and others fearing a 'sell-the-news' event as retail traders pivot toward individual stock allocations.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently trending as a proxy play for the highly anticipated SpaceX IPO, with community members actively debating its valuation relative to its SpaceX equity stake. While investors are bullish on the company's long-term turnaround potential and ownership exposure, the stock is experiencing significant volatility driven by market maker activity, aggressive options trading, and intense debates over the timing of regulatory deal closures.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is trending as investors debate the impact of a large-scale ATM offering against the backdrop of the highly anticipated SpaceX IPO and broader AI exposure. The community is sharply divided, with many viewing the recent price pullback as a strategic buying opportunity while others express significant frustration over management's decision to issue new shares amid pre-IPO volatility.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

The ERShares Private-Public Crossover ETF is seeing heightened interest as investors look for alternative ways to gain exposure to SpaceX ahead of its highly anticipated IPO. While some in the community express frustration over the fund's recent price stagnation compared to direct proxies, others view it as a safer, liquid way to hold pre-IPO assets while avoiding the significant premiums often seen in closed-end funds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced the presentation of initial data from the randomized Phase 2 trial (Duravelo-2) evaluating...

Bicycle Therapeutics (NASDAQ:BCYC) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen cut shares of Bicycle Therapeutics from a 'hold' rating to a 'sell' rating in a research report on Saturday...

Bicycle Therapeutics (NASDAQ:BCYC) Announces Earnings Results, Misses Estimates By $0.25 EPS

Bicycle Therapeutics (NASDAQ:BCYC - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.87) earnings per share (EPS) for the quarter, missing analysts...

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today...

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell re...

Bicycle Therapeutics (BCYC) to Release Quarterly Earnings on Thursday

Bicycle Therapeutics (NASDAQ:BCYC) will be releasing its Q1 2026 earnings before the market opens on Thursday, April 30. (View Earnings Report at...

Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced updates from its EphA2 pipeline at the American Association for Cancer Research (AACR) Annual...

Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to Trade

The mean of analysts' price targets for Bicycle Therapeutics (BCYC) points to a 137.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Morgan Stanley Has Lowered Expectations for Bicycle Therapeutics (NASDAQ:BCYC) Stock Price

Morgan Stanley lowered their target price on shares of Bicycle Therapeutics from $13.00 to $12.00 and set an "equal weight" rating for the company in a report on Wednesday...

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.57	--	--	N/A
Q1 '26	-$0.62	-$0.87	-40.12%	MISSED
Q4 '25	-$0.94	-$0.29	69.06%	BEAT
Q3 '25	-$1.08	-$0.85	21.13%	BEAT
Q2 '25	-$0.95	-$1.14	-20.49%	MISSED

BCYCBicycle Therapeutics Plc - ADR

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest BCYC News